12.30
0.24%
-0.03
Handel nachbörslich:
12.27
-0.03
-0.24%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CDMO?
Forum
Prognose
Aktiensplit
Finanzdaten der Avid Bioservices Inc-Aktie (CDMO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-01-31 | 2023-10-31 | 2023-07-31 | 2023-04-30 | 2023-01-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
33.16%
33.81
|
25.39 | 37.73 | 39.80 | 38.02 |
Cost Of Revenue |
4.56%
31.43
|
30.06 | 33.63 | 31.41 | 28.19 |
Gross Profit |
151.08%
2.383
|
-4.665 | 4.10 | 8.391 | 9.825 |
Operating Expenses |
2.67%
6.382
|
6.557 | 6.263 | 7.559 | 7.107 |
Interest Income/Expense |
8.70%
0.875
|
0.805 | 0.775 | 0.759 | 0.62 |
Benefits Costs and Expenses |
9.63%
40.87
|
37.28 | 40.41 | 39.35 | 35.49 |
Costs And Expenses |
9.63%
40.87
|
37.28 | 40.41 | -80.03 | 35.49 |
Depreciation and Amortization |
0.00%
2.80
|
2.80 | 2.60 | 1.90 | 1.90 |
Operating Income/Loss |
64.36%
-3.999
|
-11.22 | -2.163 | 0.832 | 2.718 |
Income/Loss From Continuing Operations Before Tax |
40.62%
-7.058
|
-11.89 | -2.68 | 0.448 | 2.53 |
Income Tax Expense/Benefit, Deferred |
53.13%
-1.115
|
-2.379 | -0.599 | 0.941 | 2.067 |
Income Tax Expense/Benefit |
55.76%
-1.052
|
-2.378 | -0.587 | 0.757 | 2.069 |
Income/Loss From Continuing Operations After Tax |
36.84%
-6.006
|
-9.509 | -2.093 | -0.309 | 0.461 |
Net Income/Loss
|
36.84%
-6.006
|
-9.509 | -2.093 | -0.309 | 0.461 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.27%
63.32
|
63.15 | 62.84 | 0.102 | 62.39 |
Diluted Average Shares |
0.27%
63.32
|
63.15 | 62.84 | 0.148 | 63.73 |
Basic Earnings Per Share |
40.00%
-0.09
|
-0.15 | -0.03 | - | 0.01 |
Diluted Earnings Per Share |
40.00%
-0.09
|
-0.15 | -0.03 | - | 0.01 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):